Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity
Abstract
:1. Introduction
2. Review
2.1. Understanding the Prevalence of PCOS
2.2. Effect of the Diagnostic Criteria on Prevalence
2.3. Prevalence of PCOS across the US
2.4. Prevalence of PCOS in Caucasians across the World
2.5. The Prevalence of PCOS across Different Races/Ethnicities
2.5.1. Asian
2.5.2. Hispanic
2.5.3. African American
2.5.4. Indigenous Australian
2.5.5. Greek Islanders
3. Conclusions
Future Research
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Abbreviations
PCOS | Polycystic Ovarian Syndrome |
NIH | National Institute of Health |
ESHRE | European Society of Human Reproduction and Embryology |
ASRM | American Society for Reproductive Medicine |
AE | Androgen Excess Society |
ROT | Rotterdam criteria |
US | United States of America |
BMI | Body Mass Index |
HOMA | Homeostasis Model Assessment |
References
- Okoroh, E.M.; Hooper, W.C.; Atrash, H.K.; Yusuf, H.R.; Boulet, S.L. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003–2008. Obstet. Gynecol. 2012, 207, 299.e1–299.e7. [Google Scholar] [CrossRef] [PubMed]
- March, W.A.; Moore, V.M.; Willson, K.J.; Phillips, D.I.; Norman, R.J.; Davies, M.J. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 2010, 25, 544–551. [Google Scholar] [CrossRef] [PubMed]
- Azziz, R.; Woods, K.S.; Reyna, R.; Key, T.J.; Knochenhauer, E.S.; Yildiz, B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 2004, 89, 2745–2749. [Google Scholar] [CrossRef] [PubMed]
- Knochenhauer, E.S.; Key, T.J.; Kahsar-Miller, M.; Waggoner, W.; Boots, L.R.; Azziz, R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J. Clin. Endocrinol. Metab. 1998, 83, 3078–3082. [Google Scholar] [CrossRef] [PubMed]
- Kauffman, R.P.; Baker, V.M.; Dimarino, P.; Gimpel, T.; Castracane, V.D. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: A comparison of two distinct populations. Am. J. Obstet. Gynecol. 2002, 187, 1362–1369. [Google Scholar] [CrossRef] [PubMed]
- Azziz, R.; Carmina, E.; Dewailly, D.; Diamanti-Kandarakis, E.; Escobar-Morreale, H.F.; Futterweit, W.; Janssen, O.E.; Legro, R.S.; Norman, R.J.; Taylor, A.E.; et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society: The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil. Steril. 2009, 91, 456–488. [Google Scholar] [CrossRef] [PubMed]
- Carmina, E. Diagnosis of polycystic ovary syndrome: From NIH criteria to ESHRE-ASRM guidelines. Minerva Ginecol. 2004, 56, 1–6. [Google Scholar] [PubMed]
- Broekmans, F.J.; Knauff, E.A.; Valkenburg, O.; Laven, J.S.; Eijkemans, M.J.; Fauser, B.C. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006, 113, 1210–1217. [Google Scholar] [CrossRef] [PubMed]
- Futterweit, W. Polycystic ovary syndrome: Clinical perspectives and management. Obstet. Gynecol. Surv. 1999, 54, 403–413. [Google Scholar] [CrossRef] [PubMed]
- Mandrelle, K.; Kamath, M.S.; Bondu, D.J.; Chandy, A.; Aleyamma, T.; George, K. Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India. J. Hum. Reprod. Sci. 2012, 5, 26–31. [Google Scholar] [PubMed]
- Legro, R.S.; Kunselman, A.R.; Dodson, W.C.; Dunaif, A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 1999, 84, 165–169. [Google Scholar] [CrossRef] [PubMed]
- Amato, M.C.; Galluzzo, A.; Finocchiaro, S.; Criscimanna, A.; Giordano, C. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome. Clin. Endocrinol. 2008, 69, 52–60. [Google Scholar] [CrossRef] [PubMed]
- Garad, R.; Teede, H.; Moran, L. An evidence-based guideline for Polycystic Ovary Syndrome. Aust. Nurs. J. 2011, 19, 30–33. [Google Scholar] [PubMed]
- Johnson, T.; Kaplan, L.; Ouyang, P.; Rizza, R. National Institutes of Health Evidence-Based Methodology Workshop on Polycystic Ovary syndrome; National Institutes of Health: Bethesda, MD, USA, 2012; pp. 1–14.
- Draft Summary and Recommendations of International Evidenced-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. 2018. Available online: http://pcos-cre.edu.au/wp-content/uploads/2018/02/PCOS-guideline-summary-and-recommendations_PC-DRAFT_FINAL-V2-050218-1.pdf (accessed on 28 October 2018).
- Meurer, L.N.; Kroll, A.P.; Jamieson, B.; Yousefi, P. Clinical inquiries. What is the best way to diagnose polycystic ovarian syndrome? J. Fam. Pract. 2006, 55, 351–352, 354. [Google Scholar] [PubMed]
- Zawadzki, J.K.; Dunaif, A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In Polycystic Ovary Syndrome; Dunaif, A., Givens, J.R., Haseltine, F.P., Merriam, G.E., Eds.; Blackwell Scientific Inc.: Boston, MA, USA, 1992; pp. 377–384. [Google Scholar]
- Lim, S.S.; Norman, R.J.; Davies, M.J.; Moran, L.J. The effect of obesity on polycystic ovary syndrome: A systematic review and meta-analysis. Obes. Rev. 2013, 14, 95–109. [Google Scholar] [CrossRef] [PubMed]
- Yildiz, B.; Bozdag, G.; Yapici, Z.; Esinler, I.; Yarali, H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. 2012, 27, 3067–3073. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Skiba, M.; Islam, R.; Bell, R.; Davis, S. Understanding variation in prevalence estimates of polycystic ovary syndrome: A systematic review and meta-analysis. Hum. Reprod. Update 2018, 694–709. [Google Scholar] [CrossRef] [PubMed]
- Copp, T.; Jansen, J.; Doust, J.; Mol, B.W.; Dokras, A.; McCaffery, K. Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome? BMJ 2017, 358, j3694. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dewailly, D.; Lujan, M.E.; Carmina, E.; Cedars, M.I.; Laven, J.; Norman, R.J.; Escobar-Morreale, H.F. Definition and significance of polycystic ovarian morphology: A task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum. Reprod. Update 2013, 20, 334–352. [Google Scholar] [CrossRef] [PubMed]
- Yildiz, B.O.; Bolour, S.; Woods, K.; Moore, A.; Azziz, R. Visually scoring hirsutism. Hum. Reprod. Update 2009, 16, 51–64. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carmina, E.; Koyama, T.; Chang, L.; Stanczyk, F.Z.; Lobo, R.A. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am. J. Obstet. Gynecol. 1992, 167, 1807–1812. [Google Scholar] [CrossRef]
- Chang, A.Y.; Oshiro, J.; Ayers, C.; Auchus, R.J. Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study. Clin. Endocrinol. 2016, 85, 92–99. [Google Scholar] [CrossRef] [PubMed]
- Li, S.; Zhu, D.; Duan, H.; Tan, Q. Genetic investigation into ethnic disparity in polycystic ovarian syndrome. Gynecol. Endocrinol. 2013, 29, 878–882. [Google Scholar] [CrossRef] [PubMed]
- Zhao, Y.; Qiao, J. Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids 2013, 78, 755–760. [Google Scholar] [CrossRef] [PubMed]
- Asuncion, M.; Calvo, R.M.; San Millan, J.L.; Sancho, J.; Avila, S.; Escobar-Morreale, H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 2000, 85, 2434–2438. [Google Scholar] [CrossRef] [PubMed]
- Razak, F.; Anand, S.; Vuksan, V.; Davis, B.; Jacobs, R.; Teo, K.K.; Yusuf, S. SHARE Investigators: Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: A cross-sectional population-based study. Int. J. Obes. 2005, 29, 656–667. [Google Scholar] [CrossRef] [PubMed]
- Dunstan, D.W.; Zimmet, P.Z.; Welborn, T.A.; De Courten, M.P.; Cameron, A.J.; Sicree, R.A.; Dwyer, T.; Colagiuri, S.; Jolley, D.; Knuiman, M.; et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002, 25, 829–834. [Google Scholar] [CrossRef] [PubMed]
- Zhu, S.; Wang, Z.; Heshka, S.; Heo, M.; Faith, M.S.; Heymsfield, S.B. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: Clinical action thresholds. Am. J. Clin. Nutr. 2002, 76, 743–749. [Google Scholar] [CrossRef] [PubMed]
- Ogden, C.L.; Carroll, M.D.; Kit, B.K.; Flegal, K.M. Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief 2012, 82, 1–8. [Google Scholar]
- Davis, S.R.; Knight, S.; White, V.; Claridge, C.; Davis, B.J.; Bell, R. Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women. Gynecol. Endocrinol. 2002, 16, 443–446. [Google Scholar] [CrossRef] [PubMed]
- Ding, T.; Hardiman, P.J.; Petersen, I.; Wang, F.; Qu, F.; Baio, G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: A systematic review and meta-analysis. Oncotarget 2017, 8. [Google Scholar] [CrossRef] [PubMed]
- Mani, H.; Davies, M.J.; Bodicoat, D.H.; Levy, M.J.; Gray, L.J.; Howlett, T.A.; Khunti, K. Clinical characteristics of polycystic ovary syndrome: Investigating differences in White and South Asian women. Clin. Endocrinol. 2015, 83, 542–549. [Google Scholar] [CrossRef] [PubMed]
- Huang, Z.; Yong, E. Ethnic differences: Is there an Asian phenotype for polycystic ovarian syndrome? Best Pract. Res. Clin. Obstet. Gynaecol. 2016, 37, 46–55. [Google Scholar] [CrossRef] [PubMed]
- Kumarapeli, V.; Seneviratne Rde, A.; Wijeyaratne, C.N.; Yapa, R.M.; Dodampahala, S.H. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am. J. Epidemiol. 2008, 168, 321–328. [Google Scholar] [CrossRef] [PubMed]
- Azziz, R.; Marin, C.; Hoq, L.; Badamgarav, E.; Song, P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J. Clin. Endocrinol. Metab. 2005, 90, 4650–4658. [Google Scholar] [CrossRef] [PubMed]
- Wijeyaratne, C.N.; Balen, A.H.; Barth, J.H.; Belchetz, P.E. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: Is there a difference? Clin. Endocrinol. 2002, 57, 343–350. [Google Scholar] [CrossRef]
- Rodin, D.A.; Bano, G.; Bland, J.M.; Taylor, K.; Nussey, S.S. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin. Endocrinol. 1998, 49, 91–99. [Google Scholar] [CrossRef]
- Shannon, M.; Wang, Y. Polycystic ovary syndrome: A common but often unrecognized condition. J. Midwifery Women Health 2012, 57, 221–230. [Google Scholar] [CrossRef] [PubMed]
- Chen, X.; Yang, D.; Mo, Y.; Li, L.; Chen, Y.; Huang, Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 139, 59–64. [Google Scholar] [CrossRef] [PubMed]
- Moran, C.; Tena, G.; Moran, S.; Ruiz, P.; Reyna, R.; Duque, X. Prevalence of polycystic ovary syndrome and related disorders in mexican women. Gynecol. Obstet. Investig. 2010, 69, 274–280. [Google Scholar] [CrossRef] [PubMed]
- Goodarzi, M.O.; Quinones, M.J.; Azziz, R.; Rotter, J.I.; Hsueh, W.A.; Yang, H. Polycystic ovary syndrome in Mexican-Americans: Prevalence and association with the severity of insulin resistance. Fertil. Steril. 2005, 84, 766–769. [Google Scholar] [CrossRef] [PubMed]
- Chan, J.L.; Sujata, K.; Vanky, E.; Morin-Papunen, L.; Piltonen, T.; Puurunen, J.; Anuja, D. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: A regional cross-sectional study. Am. J. Obstet. Gynecol. 2017, 217, 189.e1–189.e8. [Google Scholar] [CrossRef] [PubMed]
- Diamanti-Kandarakis, E.; Kouli, C.R.; Bergiele, A.T.; Filandra, F.A.; Tsianateli, T.C.; Spina, G.G.; Zapanti, E.D.; Bartzis, M.I. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J. Clin. Endocrinol. Metab. 1999, 84, 4006–4011. [Google Scholar] [CrossRef] [PubMed]
- Kyrkou, G.; Trakakis, E.; Attilakos, A.; Panagopoulos, P.; Chrelias, C.; Papadimitriou, A.; Papantoniou, N. Metabolic syndrome in Greek women with polycystic ovary syndrome: Prevalence, characteristics and associations with body mass index. A prospective controlled study. Arch. Gynecol. Obstet. 2016, 293, 915–923. [Google Scholar] [CrossRef] [PubMed]
- Azziz, R.; Dumesic, D.A.; Goodarzi, M.O. Polycystic ovary syndrome: An ancient disorder? Fertil. Steril. 2011, 95, 1544–1548. [Google Scholar] [CrossRef] [PubMed]
National Institutes of Health (NIH) 1990 [17] | Rotterdam 2003 [7] | AE-PCOS Society 2006 [6] | NIH 2012/International PCOS Guidelines 2018 [14,15] |
---|---|---|---|
|
|
|
|
First developed and most commonly used criteria today | Formulated to expand on NIH diagnostic definition | Formulated to provide an evidence-based definition | Encouraged a name change (2012 only) and identifying sub-phenotypes |
Study Authors | Objectives | Main Findings | Strengths and Limitations |
---|---|---|---|
Okoroh et al. [1] | Compare regional prevalence of PCOS across US |
|
|
Study Authors | Objectives | Main Findings | Strengths and Limitations |
---|---|---|---|
Asuncion et al. [28] | Assess prevalence in Caucasian women in Madrid, Spain |
|
|
March et al. [2] | Assess prevalence in Adelaide, Australia |
|
|
Study Authors | Objectives | Main Findings | Strengths and Limitations |
---|---|---|---|
Kumarapeli et al. [37] | Assess prevalence in South Asian women ages 15–39 |
|
|
Ding et al. [34] | Asses prevalence among Chinese, Caucasian, Middle Eastern, and African American |
| |
Chen et al. [42] | Assess prevalence among women in Southern China |
|
|
Moran et al. [43] | Assess prevalence in Mexico City, Mexico |
|
|
Goodarzi et al. [44] | Assess prevalence in Mexican-American women |
|
|
Knochenhauer et al. [4] | Assess prevalence in Caucasian and Black women in Southeastern United States |
|
|
Azziz et al. [3] | Assess prevalence in Caucasian and Black women in Southeastern United States |
|
|
Davis et al. [33] | Assess prevalence in indigenous Australian women |
|
|
Diamanti-Kandarakis et al. [46] | Assess prevalence in women on Greek island of Lesbos |
|
|
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wolf, W.M.; Wattick, R.A.; Kinkade, O.N.; Olfert, M.D. Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity. Int. J. Environ. Res. Public Health 2018, 15, 2589. https://doi.org/10.3390/ijerph15112589
Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity. International Journal of Environmental Research and Public Health. 2018; 15(11):2589. https://doi.org/10.3390/ijerph15112589
Chicago/Turabian StyleWolf, Wendy M., Rachel A. Wattick, Olivia N. Kinkade, and Melissa D. Olfert. 2018. "Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity" International Journal of Environmental Research and Public Health 15, no. 11: 2589. https://doi.org/10.3390/ijerph15112589